These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23691418)

  • 1. A case of hyperimmunoglobulinemia d syndrome successfully treated with canakinumab.
    Tsitsami E; Papadopoulou C; Speletas M
    Case Rep Rheumatol; 2013; 2013():795027. PubMed ID: 23691418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome.
    van der Hilst JCH; Bodar EJ; Barron KS; Frenkel J; Drenth JPH; van der Meer JWM; Simon A;
    Medicine (Baltimore); 2008 Nov; 87(6):301-310. PubMed ID: 19011501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa.
    Stojanov S; Lohse P; Lohse P; Hoffmann F; Renner ED; Zellerer S; Kéry A; Shin YS; Haas D; Hoffmann GF; Belohradsky BH
    Arthritis Rheum; 2004 Jun; 50(6):1951-8. PubMed ID: 15188372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyper-IgD and periodic fever syndrome: a new MVK mutation (p.R277G) associated with a severe phenotype.
    Santos JA; Aróstegui JI; Brito MJ; Neves C; Conde M
    Gene; 2014 Jun; 542(2):217-20. PubMed ID: 24656624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canakinumab for the treatment of hyperimmunoglobulin D syndrome.
    Sánchez-Manubens J; Iglesias E; Anton J
    Expert Rev Clin Immunol; 2019 Mar; 15(3):215-220. PubMed ID: 30652926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mevalonate kinase deficiency in 2016].
    Galeotti C; Georgin-Lavialle S; Sarrabay G; Touitou I; Koné-Paut I
    Rev Med Interne; 2018 Apr; 39(4):265-270. PubMed ID: 27659743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and clinical features of hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) and spectrum of mevalonate kinase (MVK) mutations in German children.
    Lainka E; Neudorf U; Lohse P; Timmann C; Bielak M; Stojanov S; Huss K; von Kries R; Niehues T
    Rheumatol Int; 2012 Oct; 32(10):3253-60. PubMed ID: 22038276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome.
    Takada K; Aksentijevich I; Mahadevan V; Dean JA; Kelley RI; Kastner DL
    Arthritis Rheum; 2003 Sep; 48(9):2645-51. PubMed ID: 13130485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome.
    Haas D; Hoffmann GF
    Orphanet J Rare Dis; 2006 Apr; 1():13. PubMed ID: 16722536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome.
    Arostegui JI; Anton J; Calvo I; Robles A; Iglesias E; López-Montesinos B; Banchereau R; Hong S; Joubert Y; Junge G; Pascual V; Yagüe J
    Arthritis Rheumatol; 2017 Aug; 69(8):1679-1688. PubMed ID: 28482144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MVK gene abnormality and new approach to treatment of hyper IgD syndrome and periodic fever syndrome].
    Naruto T
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Apr; 30(2):86-9. PubMed ID: 17473510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group.
    Drenth JP; Cuisset L; Grateau G; Vasseur C; van de Velde-Visser SD; de Jong JG; Beckmann JS; van der Meer JW; Delpech M
    Nat Genet; 1999 Jun; 22(2):178-81. PubMed ID: 10369262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutations of MVK gene in Japanese family members affected with hyperimmunoglobulinemia D and periodic fever syndrome.
    Mizuno T; Sakai H; Nishikomori R; Oshima K; Ohara O; Hata I; Shigematsu Y; Ishige T; Tamura K; Arakawa H
    Rheumatol Int; 2012 Dec; 32(12):3761-4. PubMed ID: 22159817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperimmunoglobulinemia D and periodic fever syndrome in children. Review on therapy with biological drugs and case report.
    Korppi M; Van Gijn ME; Antila K
    Acta Paediatr; 2011 Jan; 100(1):21-5. PubMed ID: 20712835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel missense mutation in MVK associated with MK deficiency and dyserythropoietic anemia.
    Samkari A; Borzutzky A; Fermo E; Treaba DO; Dedeoglu F; Altura RA
    Pediatrics; 2010 Apr; 125(4):e964-8. PubMed ID: 20194276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyper-immunoglobulin A in the hyperimmunoglobulinemia D syndrome.
    Klasen IS; Göertz JH; van de Wiel GA; Weemaes CM; van der Meer JW; Drenth JP
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):58-61. PubMed ID: 11139196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal hepatitis as first manifestation of hyperimmunoglobulinemia d syndrome.
    von Linstow ML; Rosenfeldt V
    Case Rep Pediatr; 2014; 2014():936890. PubMed ID: 24716072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience.
    Kostjukovits S; Kalliokoski L; Antila K; Korppi M
    Eur J Pediatr; 2015 Jun; 174(6):707-14. PubMed ID: 25721923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome.
    Ammouri W; Cuisset L; Rouaghe S; Rolland MO; Delpech M; Grateau G; Ravet N
    Rheumatology (Oxford); 2007 Oct; 46(10):1597-600. PubMed ID: 17804452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current advances in the understanding and treatment of mevalonate kinase deficiency.
    Esposito S; Ascolese B; Senatore L; Bosis S; Verrecchia E; Cantarini L; Rigante D
    Int J Immunopathol Pharmacol; 2014; 27(4):491-8. PubMed ID: 25572728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.